Compare ADAM & INMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ADAM | INMD |
|---|---|---|
| Founded | 2003 | 2008 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 762.2M | 879.2M |
| IPO Year | N/A | 2019 |
| Metric | ADAM | INMD |
|---|---|---|
| Price | $7.95 | $14.62 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 6 |
| Target Price | $8.25 | ★ $16.75 |
| AVG Volume (30 Days) | 650.3K | ★ 1.2M |
| Earning Date | 02-18-2026 | 02-10-2026 |
| Dividend Yield | ★ 11.69% | N/A |
| EPS Growth | N/A | ★ 20.42 |
| EPS | 0.19 | ★ 2.21 |
| Revenue | $216,781,000.00 | ★ $364,494,000.00 |
| Revenue This Year | $11.01 | N/A |
| Revenue Next Year | $41.33 | $3.33 |
| P/E Ratio | $40.63 | ★ $6.84 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.02 | $13.14 |
| 52 Week High | $8.76 | $19.78 |
| Indicator | ADAM | INMD |
|---|---|---|
| Relative Strength Index (RSI) | 49.23 | 47.19 |
| Support Level | $7.67 | $14.72 |
| Resistance Level | $8.13 | $16.67 |
| Average True Range (ATR) | 0.24 | 0.55 |
| MACD | -0.07 | -0.05 |
| Stochastic Oscillator | 26.26 | 27.52 |
Adamas Trust Inc is an internally-managed REIT for U.S. federal income tax purposes, in the business of acquiring, investing in, financing and managing primarily mortgage-related single-family and multi-family residential assets. Its objective is to deliver long-term stable distributions to its stockholders over changing economic conditions through a combination of net interest spread and capital gains from a diversified investment portfolio. The company's investment portfolio includes credit sensitive single-family and multi-family assets.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF and Morpheus8. The majority of its revenue comes from the United States.